These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 27894912

  • 1. Hearing thresholds at high frequency in patients with cystic fibrosis: a systematic review.
    Caumo DTM, Geyer LB, Teixeira AR, Barreto SSM.
    Braz J Otorhinolaryngol; 2017; 83(4):464-474. PubMed ID: 27894912
    [Abstract] [Full Text] [Related]

  • 2. High frequency hearing thresholds and product distortion otoacoustic emissions in cystic fibrosis patients.
    Geyer LB, Menna Barreto SS, Weigert LL, Teixeira AR.
    Braz J Otorhinolaryngol; 2015; 81(6):589-97. PubMed ID: 26480907
    [Abstract] [Full Text] [Related]

  • 3. High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis.
    Al-Malky G, Dawson SJ, Sirimanna T, Bagkeris E, Suri R.
    J Cyst Fibros; 2015 Mar; 14(2):248-54. PubMed ID: 25127922
    [Abstract] [Full Text] [Related]

  • 4. Chirp-Evoked Otoacoustic Emissions and Middle Ear Absorbance for Monitoring Ototoxicity in Cystic Fibrosis Patients.
    Garinis AC, Keefe DH, Hunter LL, Fitzpatrick DF, Putterman DB, McMillan GP, Gold JA, Feeney MP.
    Ear Hear; 2018 Mar; 39(1):69-84. PubMed ID: 28708814
    [Abstract] [Full Text] [Related]

  • 5. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [Abstract] [Full Text] [Related]

  • 6. Aminoglycoside ototoxicity in cystic fibrosis. Evaluation by high-frequency audiometry.
    McRorie TI, Bosso J, Randolph L.
    Am J Dis Child; 1989 Nov; 143(11):1328-32. PubMed ID: 2816859
    [Abstract] [Full Text] [Related]

  • 7. Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment.
    Harruff EE, Kil J, Ortiz MGT, Dorgan D, Jain R, Poth EA, Fifer RC, Kim YJM, Shoup AG, Flume PA.
    J Cyst Fibros; 2021 Mar; 20(2):288-294. PubMed ID: 33341407
    [Abstract] [Full Text] [Related]

  • 8. Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin.
    Garinis A, Gleser M, Johns A, Larsen E, Vachhani J.
    J Cyst Fibros; 2021 Mar; 20(2):278-283. PubMed ID: 32713806
    [Abstract] [Full Text] [Related]

  • 9. Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions.
    Al-Malky G, Suri R, Dawson SJ, Sirimanna T, Kemp D.
    Int J Audiol; 2011 Feb; 50(2):112-22. PubMed ID: 21265638
    [Abstract] [Full Text] [Related]

  • 10. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G.
    Int J Pediatr Otorhinolaryngol; 2001 May 31; 59(1):47-57. PubMed ID: 11376818
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of implementing routine hearing screening using a tablet audiometer for pediatric cystic fibrosis patients receiving high-dose IV aminoglycosides.
    Huang SP, McKinzie CJ, Tak CR.
    J Manag Care Spec Pharm; 2021 Feb 31; 27(2):157-165. PubMed ID: 33506732
    [Abstract] [Full Text] [Related]

  • 12. Auditory monitoring in ototoxicity.
    Jacob LC, Aguiar FP, Tomiasi AA, Tschoeke SN, Bitencourt RF.
    Braz J Otorhinolaryngol; 2006 Feb 31; 72(6):836-44. PubMed ID: 17308839
    [Abstract] [Full Text] [Related]

  • 13. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G, Namysłowski G, Hajduk A, Polok A, Tomaszewska R, Misiołek M.
    Otolaryngol Pol; 2006 Feb 31; 60(3):415-20. PubMed ID: 16989457
    [Abstract] [Full Text] [Related]

  • 14. An audiological profile of patients infected with multi-drug resistant tuberculosis at a district hospital in KwaZulu-Natal.
    Appana D, Joseph L, Paken J.
    S Afr J Commun Disord; 2016 Nov 25; 63(1):e1-e12. PubMed ID: 28155306
    [Abstract] [Full Text] [Related]

  • 15. Ototoxicity (cochleotoxicity) classifications: A review.
    Crundwell G, Gomersall P, Baguley DM.
    Int J Audiol; 2016 Nov 25; 55(2):65-74. PubMed ID: 26618898
    [Abstract] [Full Text] [Related]

  • 16. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
    Stavroulaki P, Apostolopoulos N, Dinopoulou D, Vossinakis I, Tsakanikos M, Douniadakis D.
    Int J Pediatr Otorhinolaryngol; 1999 Nov 05; 50(3):177-84. PubMed ID: 10595663
    [Abstract] [Full Text] [Related]

  • 17. The role of routine hearing screening in children with cystic fibrosis on aminoglycosides: A systematic review.
    Farzal Z, Kou YF, St John R, Shah GB, Mitchell RB.
    Laryngoscope; 2016 Jan 05; 126(1):228-35. PubMed ID: 26152803
    [Abstract] [Full Text] [Related]

  • 18. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JP.
    Pediatrics; 2004 Jul 05; 114(1):e111-8. PubMed ID: 15231982
    [Abstract] [Full Text] [Related]

  • 19. Tablet and web-based audiometry to screen for hearing loss in adults with cystic fibrosis.
    Vijayasingam A, Frost E, Wilkins J, Gillen L, Premachandra P, Mclaren K, Gilmartin D, Picinali L, Vidal-Diez A, Borsci S, Ni MZ, Tang WY, Morris-Rosendahl D, Harcourt J, Elston C, Simmonds NJ, Shah A.
    Thorax; 2020 Aug 05; 75(8):632-639. PubMed ID: 32409613
    [Abstract] [Full Text] [Related]

  • 20. Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.
    Mulheran M, Hyman-Taylor P, Tan KH, Lewis S, Stableforth D, Knox A, Smyth A.
    Antimicrob Agents Chemother; 2006 Jul 05; 50(7):2293-9. PubMed ID: 16801404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.